IL34 and rheumatoid arthritis: Although systemic IL-34 was shown to exacerbate RA (11, 24), the deleterious role of IL-34 in RA has remained controversial through various studies including the latest finding suggesting that IL-34 is beneficial in the effector phase of RA (9).